192 related articles for article (PubMed ID: 38222108)
1. T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis.
Fan Z; Liu Y; Li C; Jiang Y; Wang N; Wang M; Li C; Diao Y; Qiu W; Zhu X; Wang G; Cai S; Yang T; Lv G
iScience; 2024 Jan; 27(1):108701. PubMed ID: 38222108
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response.
Zhang Z; Wang ZX; Chen YX; Wu HX; Yin L; Zhao Q; Luo HY; Zeng ZL; Qiu MZ; Xu RH
Genome Med; 2022 Apr; 14(1):45. PubMed ID: 35488273
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis.
Chen S; Huang M; Zhang L; Huang Q; Wang Y; Liang Y
Comput Struct Biotechnol J; 2024 Dec; 23():369-383. PubMed ID: 38226313
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
5. [
Zhang Z; Tan J; Yu Z; Liu C; Wang J; Wu D; Bai X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):667-679. PubMed ID: 37313807
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating PD-1
Yang Z; Deng Y; Cheng J; Wei S; Luo H; Liu L
Front Oncol; 2021; 11():695006. PubMed ID: 34604032
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication.
Chen D; Liu P; Lu X; Li J; Qi D; Zang L; Lin J; Liu Y; Zhai S; Fu D; Weng Y; Li H; Shen B
J Exp Clin Cancer Res; 2024 Apr; 43(1):125. PubMed ID: 38664705
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
[TBL] [Abstract][Full Text] [Related]
9. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma.
Wang K; Yu M; Zhang Z; Yin R; Chen Q; Zhao X; Yu H
Transl Cancer Res; 2023 May; 12(5):1270-1289. PubMed ID: 37304554
[TBL] [Abstract][Full Text] [Related]
11. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
12. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer.
Pan H; Pan J; Wu J
Front Immunol; 2022; 13():934221. PubMed ID: 35967425
[TBL] [Abstract][Full Text] [Related]
14. The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma.
Li X; Dai Z; Wu X; Zhang N; Zhang H; Wang Z; Zhang X; Liang X; Luo P; Zhang J; Liu Z; Zhou Y; Cheng Q; Chang R
Front Immunol; 2022; 13():749241. PubMed ID: 35529878
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and immunotherapy response in bladder cancer.
Shi X; Dong A; Yang Y; Zheng G; Wang N; Yang C; Wang Y; Lu J; Jia X
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9733-9746. PubMed ID: 37244876
[TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
17. Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature.
Liu G; Li F; Ge Y; Shi Y; Ren F; Zhu L
J Cancer; 2023; 14(17):3335-3350. PubMed ID: 37928426
[No Abstract] [Full Text] [Related]
18. Different Glucose Metabolic Features According to Cancer and Immune Cells in the Tumor Microenvironment.
Choi H; Na KJ
Front Oncol; 2021; 11():769393. PubMed ID: 34966676
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
20. A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies.
Xu Y; Chen Y; Niu Z; Xing J; Yang Z; Yin X; Guo L; Zhang Q; Qiu H; Han Y
Front Med (Lausanne); 2022; 9():841568. PubMed ID: 35492358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
